相关实验视频
Updated: Jun 21, 2025

08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
10.6K
释放药物的隐形眼镜:进展,挑战和前景
Dongdong Gao1,2, Chunxiao Yan3, Yong Wang4
1Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning 116033, China.
Biointerphases
|July 10, 2024
概括
释放药物的角膜隐形眼镜 (DECL) 为眼睛治疗提供了更好的生物可用性,克服了传统眼药的低吸收性. 本综述考察了DECL的准备,药物输送,安全性以及眼科治疗的未来潜力.
科学领域:
- 眼科医生 眼科 眼科
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
背景情况:
- 局部眼科溶液 (眼滴) 由于安全性和易于使用,广泛用于眼部疾病.
- 然而,较低的眼部生物利用率 (<5%) 限制了传统眼滴的疗效.
- 药物释放角膜隐形眼镜 (DECL) 作为持续药物输送和增强生物可用性的替代品被探索.
研究的目的:
- 系统地审查药物释放角膜隐形眼镜 (DECL) 的进展.
- 检查包括准备,药物加载,释放机制和眼壁透等关键方面.
- 评估安全性,生物相容性和临床应用的未来前景.
主要方法:
- 关于DECLs的综合文献综述.
- 对制备材料和药物加载策略的分析.
- 对药物释放机制和眼睛透增强技术的评估.
主要成果:
- DECL显示了持续药物释放和改善生物可用性的潜力.
- 为了增强眼界屏障的透,存在各种策略.
- 讨论了体外和体外药物输送检测,安全性和生物相容性验证的方法.
结论:
- DECLs代表了对眼部疾病的有前途的药物输送系统.
- 需要进一步的研究来应对挑战并优化临床应用.
- 本综述提供了对DECL技术及其未来方向的全面概述.
相关概念视频
Drug Delivery: Miscellaneous Routes
336
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
336
Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427

